Rare lephants
Screener

Gyre Therapeutics, Inc.

GYRE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Mar 25, 2025 FORM 4
4 Mar 21, 2025 FORM 4
S-8 Mar 20, 2025 S-8
4 Mar 19, 2025 FORM 4
10-K Mar 17, 2025 10-K
8-K Mar 17, 2025 8-K
4 Mar 17, 2025 FORM 4
4 Mar 13, 2025 FORM 4
4 Mar 11, 2025 FORM 4
4 Mar 11, 2025 FORM 4
4 Mar 7, 2025 FORM 4
4 Mar 5, 2025 FORM 4
4 Mar 3, 2025 FORM 4
4 Feb 27, 2025 FORM 4
4 Feb 25, 2025 FORM 4
4 Feb 21, 2025 FORM 4
4 Feb 19, 2025 FORM 4
8-K Feb 18, 2025 8-K
4 Feb 14, 2025 FORM 4
4 Feb 12, 2025 FORM 4
4 Feb 11, 2025 FORM 4
4 Feb 6, 2025 FORM 4
4 Feb 4, 2025 FORM 4
4 Jan 31, 2025 FORM 4
4 Jan 29, 2025 FORM 4
← Newer Page 5 of 65 · 1601 filings Older →